Strong 2025 growth at Ryan Specialty (RYAN) driven by E&S focus
Ryan Specialty Holdings files its annual report describing a fast-growing specialty insurance intermediary focused on the excess and surplus (E&S) market. For 2025, revenue rose 21.3%, driven by Wholesale Brokerage, Binding Authority, and Underwriting Management operations.
Wholesale Brokerage generated $1,600.4 million in net commissions and fees, Binding Authority $370.2 million, and Underwriting Management $1,024.0 million. Diluted earnings per share were $0.47 versus $0.71 in 2024, while Adjusted diluted EPS increased from $1.79 to $1.96, reflecting strong underlying performance despite higher investments and non‑GAAP adjustments.
The company emphasizes its leadership in the E&S market, where 78% of 2025 premiums were placed, and highlights consolidation among retail brokers and carriers as a tailwind. It reports strategic acquisitions in 2025, expanded international MGAs/MGUs, and ongoing investments in technology, including generative AI and the RT Connector digital marketplace, to support scalability and innovation.
Positive
- None.
Negative
- None.
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or Other Jurisdiction of Incorporation) | (IRS Employer Identification No.) | |||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Class A Common Stock, $0.001 par value per share |
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company |
PART I | 1 |
Item 1. Business | 1 |
Item 1A. Risk Factors | 16 |
Item 1B. Unresolved Staff Comments | 48 |
Item 1C. Cybersecurity | 48 |
Item 2. Properties | 50 |
Item 3. Legal Proceedings | 50 |
Item 4. Mine Safety Disclosure | 50 |
PART II | 51 |
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 51 |
Item 6. [Reserved] | 52 |
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 53 |
Item 7A. Quantitative and Qualitative Disclosures About Market Risk | 79 |
Item 8. Financial Statements and Supplementary Data | 80 |
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 130 |
Item 9A. Controls and Procedures | 130 |
Item 9B. Other Information | 131 |
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 131 |
PART III | 132 |
Item 10. Directors, Executive Officers and Corporate Governance | 132 |
Item 11. Executive Compensation | 132 |
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 132 |
Item 13. Certain Relationships and Related Transactions, and Director Independence | 132 |
Item 14. Principal Accountant Fees and Services | 132 |
PART IV | 133 |
Item 15. Exhibits and Financial Statement Schedules | 133 |
Item 16. Form 10-K Summary | 135 |





Year Ended December 31, | ||||||
(in thousands, except percentages and per share data) | 2025 | 2024 | 2023 | |||
Revenue | ||||||
Net commissions and fees | $2,994,582 | $2,455,671 | $2,026,596 | |||
Fiduciary investment income | 56,544 | 60,039 | 50,953 | |||
Total revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Expenses | ||||||
Compensation and benefits | 1,803,397 | 1,591,077 | 1,321,029 | |||
General and administrative | 453,452 | 352,050 | 276,181 | |||
Amortization | 274,426 | 157,845 | 106,799 | |||
Depreciation | 13,089 | 9,785 | 9,038 | |||
Change in contingent consideration | 13,122 | (22,859) | 5,421 | |||
Total operating expenses | $2,557,486 | $2,087,898 | $1,718,468 | |||
Operating income | $493,640 | $427,812 | $359,081 | |||
Interest expense, net | 222,384 | 158,448 | 119,507 | |||
Income from equity method investments | (21,236) | (18,231) | (8,731) | |||
Other non-operating loss (income) | (692) | 15,041 | 10,380 | |||
Income before income taxes | $293,184 | $272,554 | $237,925 | |||
Income tax expense | 79,027 | 42,641 | 43,445 | |||
Net income | $214,157 | $229,913 | $194,480 | |||
GAAP financial measures | ||||||
Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Net commissions and fees | 2,994,582 | 2,455,671 | 2,026,596 | |||
Compensation and benefits | 1,803,397 | 1,591,077 | 1,321,029 | |||
General and administrative | 453,452 | 352,050 | 276,181 | |||
Net income | 214,157 | 229,913 | 194,480 | |||
Compensation and benefits expense ratio (1) | 59.1% | 63.2% | 63.6% | |||
General and administrative expense ratio (2) | 14.9% | 14.0% | 13.3% | |||
Net income margin (3) | 7.0% | 9.1% | 9.4% | |||
Earnings per share (4) | $0.50 | $0.78 | $0.53 | |||
Diluted earnings per share (4) | $0.47 | $0.71 | $0.52 | |||
Non-GAAP financial measures* | ||||||
Organic revenue growth rate | 10.1% | 12.8% | 15.4% | |||
Adjusted compensation and benefits expense | $1,692,000 | $1,426,674 | $1,222,342 | |||
Adjusted compensation and benefits expense ratio | 55.5% | 56.7% | 58.8% | |||
Adjusted general and administrative expense | $392,384 | $277,813 | $230,467 | |||
Adjusted general and administrative expense ratio | 12.9% | 11.0% | 11.1% | |||
Adjusted EBITDAC | $966,742 | $811,223 | $624,740 | |||
Adjusted EBITDAC margin | 31.7% | 32.2% | 30.1% | |||
Adjusted net income | $548,219 | $493,521 | $375,582 | |||
Adjusted net income margin | 18.0% | 19.6% | 18.1% | |||
Adjusted diluted earnings per share | $1.96 | $1.79 | $1.38 | |||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $1,600,427 | 53.4% | $1,489,077 | 60.7% | $111,350 | 7.5% | ||||||
Binding Authority | 370,155 | 12.4 | 320,379 | 13.0 | 49,776 | 15.5 | ||||||
Underwriting Management | 1,024,000 | 34.2 | 646,215 | 26.3 | 377,785 | 58.5 | ||||||
Total Net commissions and fees | $2,994,582 | $2,455,671 | $538,911 | 21.9% | ||||||||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $2,759,597 | 92.1% | $2,310,384 | 94.1% | $449,213 | 19.4% | ||||||
Supplemental and contingent commissions | 149,237 | 5.0 | 88,842 | 3.6 | 60,395 | 68.0 | ||||||
Loss mitigation and other fees | 85,748 | 2.9 | 56,445 | 2.3 | 29,303 | 51.9 | ||||||
Total Net commissions and fees | $2,994,582 | $2,455,671 | $538,911 | 21.9% | ||||||||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2024 | % of total | 2023 | % of total | Change | |||||||
Wholesale Brokerage | $1,489,077 | 60.7% | $1,319,056 | 65.1% | $170,021 | 12.9% | ||||||
Binding Authority | 320,379 | 13.0 | 275,961 | 13.6 | 44,418 | 16.1 | ||||||
Underwriting Management | 646,215 | 26.3 | 431,579 | 21.3 | 214,636 | 49.7 | ||||||
Total Net commissions and fees | $2,455,671 | $2,026,596 | $429,075 | 21.2% | ||||||||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2024 | % of total | 2023 | % of total | Change | |||||||
Net commissions and policy fees | $2,310,384 | 94.1% | $1,935,851 | 95.5% | $374,533 | 19.3% | ||||||
Supplemental and contingent commissions | 88,842 | 3.6 | 56,375 | 2.8 | 32,467 | 57.6 | ||||||
Loss mitigation and other fees | 56,445 | 2.3 | 34,370 | 1.7 | 22,075 | 64.2 | ||||||
Total Net commissions and fees | $2,455,671 | $2,026,596 | $429,075 | 21.2% | ||||||||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Current period Net commissions and fees revenue | $2,994,582 | $2,455,671 | $2,026,596 | |||
Less: Current period contingent commissions | (121,549) | (73,175) | (39,028) | |||
Less: Revenue attributable to sold businesses | (361) | — | — | |||
Net commissions and fees revenue excluding contingent commissions | $2,872,672 | $2,382,496 | $1,987,568 | |||
Prior period Net commissions and fees revenue | $2,455,671 | $2,026,596 | $1,711,861 | |||
Less: Prior period contingent commissions | (73,175) | (39,028) | (30,788) | |||
Less: Revenue attributable to sold businesses | (1,941) | — | — | |||
Prior period Net commissions and fees revenue excluding contingent commissions | $2,380,555 | $1,987,568 | $1,681,073 | |||
Change in Net commissions and fees revenue excluding contingent commissions | $492,117 | $394,928 | $306,494 | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions | (246,914) | (141,972) | (46,496) | |||
Impact of change in foreign exchange rates | (4,863) | (791) | (479) | |||
Organic revenue growth (Non-GAAP) | $240,340 | $252,165 | $259,519 | |||
Net commissions and fees revenue growth rate (GAAP) | 21.9 % | 21.2 % | 18.4 % | |||
Less: Impact of contingent commissions (1) | (1.2) | (1.3) | (0.2) | |||
Net commissions and fees revenue excluding contingent commissions growth rate (2) | 20.7 % | 19.9 % | 18.2 % | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) | (10.4) | (7.1) | (2.8) | |||
Impact of change in foreign exchange rates (4) | (0.2) | 0.0 | 0.0 | |||
Organic Revenue Growth Rate (Non-GAAP) | 10.1 % | 12.8 % | 15.4 % | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Compensation and Benefits Expense | $1,803,397 | $1,591,077 | $1,321,029 | |||
Acquisition-related expense | (11,033) | (15,373) | (4,186) | |||
Acquisition related long-term incentive compensation (1) | (26,581) | (24,946) | 4,334 | |||
Restructuring and related expense | — | (39,929) | (22,651) | |||
Amortization and expense related to discontinued prepaid incentives | (4,332) | (5,160) | (6,441) | |||
Equity-based compensation (2) | (49,664) | (52,038) | (31,047) | |||
IPO related expenses | (19,787) | (26,957) | (38,696) | |||
Adjusted Compensation and Benefits Expense (3) | $1,692,000 | $1,426,674 | $1,222,342 | |||
Compensation and Benefits Expense Ratio | 59.1% | 63.2% | 63.6% | |||
Adjusted Compensation and Benefits Expense Ratio | 55.5% | 56.7% | 58.8% | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
General and Administrative Expense | $453,452 | $352,050 | $276,181 | |||
Acquisition-related expense | (61,068) | (54,469) | (19,088) | |||
Restructuring and related expense | — | (19,768) | (26,626) | |||
Adjusted General and Administrative Expense (1) | $392,384 | $277,813 | $230,467 | |||
General and Administrative Expense Ratio | 14.9% | 14.0% | 13.3% | |||
Adjusted General and Administrative Expense Ratio | 12.9% | 11.0% | 11.1% | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Net Income | $214,157 | $229,913 | $194,480 | |||
Interest expense, net | 222,384 | 158,448 | 119,507 | |||
Income tax expense | 79,027 | 42,641 | 43,445 | |||
Depreciation | 13,089 | 9,785 | 9,038 | |||
Amortization | 274,426 | 157,845 | 106,799 | |||
Change in contingent consideration (1) | 13,122 | (22,859) | 5,421 | |||
EBITDAC | $816,205 | $575,773 | $478,690 | |||
Acquisition-related expense | 72,101 | 69,842 | 23,274 | |||
Acquisition related long-term incentive compensation (2) | 26,581 | 24,946 | (4,334) | |||
Restructuring and related expense | — | 59,697 | 49,277 | |||
Amortization and expense related to discontinued prepaid incentives | 4,332 | 5,160 | 6,441 | |||
Other non-operating loss (income) | (692) | 15,041 | 10,380 | |||
Equity-based compensation | 49,664 | 52,038 | 31,047 | |||
IPO related expenses | 19,787 | 26,957 | 38,696 | |||
Income from equity method investments | (21,236) | (18,231) | (8,731) | |||
Adjusted EBITDAC | $966,742 | $811,223 | $624,740 | |||
Net Income Margin | 7.0% | 9.1% | 9.4% | |||
Adjusted EBITDAC Margin | 31.7% | 32.2% | 30.1% | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Net Income | $214,157 | $229,913 | $194,480 | |||
Income tax expense | 79,027 | 42,641 | 43,445 | |||
Amortization | 274,426 | 157,845 | 106,799 | |||
Amortization of deferred debt issuance costs (1) | 9,567 | 23,930 | 12,172 | |||
Change in contingent consideration | 13,122 | (22,859) | 5,421 | |||
Acquisition-related expense | 72,101 | 69,842 | 23,274 | |||
Acquisition related long-term incentive compensation | 26,581 | 24,946 | (4,334) | |||
Restructuring and related expense | — | 59,697 | 49,277 | |||
Amortization and expense related to discontinued prepaid incentives | 4,332 | 5,160 | 6,441 | |||
Other non-operating loss (income) | (692) | 15,041 | 10,380 | |||
Equity-based compensation | 49,664 | 52,038 | 31,047 | |||
IPO related expenses | 19,787 | 26,957 | 38,696 | |||
Income from equity method investments | (21,236) | (18,231) | (8,731) | |||
Adjusted Income before Income Taxes (2) | $740,836 | $666,920 | $508,367 | |||
Adjusted tax expense (3) | (192,617) | (173,399) | (132,785) | |||
Adjusted Net Income | $548,219 | $493,521 | $375,582 | |||
Net Income Margin | 7.0% | 9.1% | 9.4% | |||
Adjusted Net Income Margin | 18.0% | 19.6% | 18.1% | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Earnings per share of Class A common stock – diluted | $0.47 | $0.71 | $0.52 | |||
Less: Net income attributed to dilutive shares and substantively vested RSUs (1) | (0.01) | — | (0.03) | |||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 0.32 | 0.14 | 0.24 | |||
Plus: Adjustments to Adjusted net income (3) | 1.22 | 0.97 | 0.67 | |||
Plus: Dilutive impact of unvested equity awards (4) | (0.04) | (0.03) | (0.02) | |||
Adjusted diluted earnings per share | $1.96 | $1.79 | $1.38 | |||
(Share count in ’000s) | ||||||
Weighted-average shares of Class A common stock outstanding – diluted | 138,246 | 132,891 | 125,745 | |||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 135,429 | 138,980 | 142,384 | |||
Plus: Dilutive impact of unvested equity awards (4) | 5,354 | 4,417 | 4,137 | |||
Adjusted diluted earnings per share diluted share count | 279,029 | 276,288 | 272,266 | |||
(in thousands) | Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | ||||
Balance at December 31, 2024 | $253,233 | $83,415 | $99,648 | $436,296 | ||||
Exchange of LLC Common Units | 34,813 | 2,466 | 9,479 | 46,758 | ||||
Interest expense | — | — | 1,112 | 1,112 | ||||
Payments | (16,067) | (8,532) | (570) | (25,169) | ||||
Balance at December 31, 2025 | $271,979 | $77,349 | $109,669 | $458,997 |
Long-term Incentive Compensation Agreements | ||
(in thousands) | December 31, 2025 | |
Current accrued compensation | $10,752 | |
Non-current accrued compensation | 19,212 | |
Total liability | $29,963 | |
Projected future expense | 44,880 | |
Total projected future cash outflows | $74,843 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2026 | $14,632 | |
2027 | 9,274 | |
2028 | 32,257 | |
2029 | 11,048 | |
Thereafter | $7,632 | |
Contingent Consideration | ||
(in thousands) | December 31, 2025 | |
Current accounts payable and accrued liabilities | $55,880 | |
Other non-current liabilities | 92,508 | |
Total liability | $148,388 | |
Projected future expense | 10,429 | |
Total projected future cash outflows | $158,817 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2026 | $57,255 | |
2027 | 89,016 | |
2028 | 6,262 | |
2029 | 4,662 | |
Thereafter | $1,622 | |
(in thousands) | Balance at December 31, 2025 | 100 BPS Increase | 100 BPS Decrease | |||
Cash and cash equivalents | $158,322 | $(1,583) | $1,583 | |||
Term Loan principal outstanding (1) | 1,683,000 | 16,830 | $(16,830) | |||
Net exposure to Interest expense, net | 15,247 | (15,247) | ||||
Cash and cash equivalents held in a fiduciary capacity | 1,426,148 | 14,261 | $(14,261) | |||
Net exposure to Fiduciary investment income | $14,261 | $(14,261) | ||||
Impact to Net income | $(985) | $985 |
Report of Independent Registered Public Accounting Firm | 81 |
Consolidated Statements of Income for the years ended December 31, 2025, 2024, and 2023 | 83 |
Consolidated Statements of Comprehensive Income for the years ended December 31, 2025, 2024, and 2023 | 84 |
Consolidated Balance Sheets as of December 31, 2025, and 2024 | 85 |
Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024, and 2023 | 86 |
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2025, 2024, and 2023 | 87 |
Notes to the Consolidated Financial Statements | 89 |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
REVENUE | ||||||
Net commissions and fees | $ | $ | $ | |||
Fiduciary investment income | ||||||
Total revenue | $ | $ | $ | |||
EXPENSES | ||||||
Compensation and benefits | ||||||
General and administrative | ||||||
Amortization | ||||||
Depreciation | ||||||
Change in contingent consideration | ( | |||||
Total operating expenses | $ | $ | $ | |||
OPERATING INCOME | $ | $ | $ | |||
Interest expense, net | ||||||
Income from equity method investments | ( | ( | ( | |||
Other non-operating loss (income) | ( | |||||
INCOME BEFORE INCOME TAXES | $ | $ | $ | |||
Income tax expense | ||||||
NET INCOME | $ | $ | $ | |||
Net income attributable to non-controlling interests, net of tax | ||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | |||
NET INCOME PER SHARE OF CLASS A COMMON STOCK: | ||||||
Basic | $ | $ | $ | |||
Diluted | $ | $ | $ | |||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON STOCK OUTSTANDING: | ||||||
Basic | ||||||
Diluted | ||||||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
NET INCOME | $ | $ | $ | |||
Net income attributable to non-controlling interests, net of tax | ||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | |||
Other comprehensive income (loss), net of tax: | ||||||
Gain on interest rate cap | ||||||
Gain on interest rate cap reclassified to earnings | ( | ( | ( | |||
Foreign currency translation adjustments | ( | |||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | |||||
Total other comprehensive income (loss), net of tax | $ | $( | $( | |||
COMPREHENSIVE INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | |||
December 31, 2025 | December 31, 2024 | |||
ASSETS | ||||
CURRENT ASSETS | ||||
Cash and cash equivalents | $ | $ | ||
Commissions and fees receivable – net | ||||
Fiduciary cash and receivables | ||||
Prepaid incentives – net | ||||
Other current assets | ||||
Total current assets | $ | $ | ||
NON-CURRENT ASSETS | ||||
Goodwill | ||||
Customer relationships | ||||
Other intangible assets | ||||
Prepaid incentives – net | ||||
Equity method investments | ||||
Property and equipment – net | ||||
Lease right-of-use assets | ||||
Deferred tax assets | ||||
Other non-current assets | ||||
Total non-current assets | $ | $ | ||
TOTAL ASSETS | $ | $ | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
CURRENT LIABILITIES | ||||
Accounts payable and accrued liabilities | $ | $ | ||
Accrued compensation | ||||
Operating lease liabilities | ||||
Short-term debt and current portion of long-term debt | ||||
Fiduciary liabilities | ||||
Total current liabilities | $ | $ | ||
NON-CURRENT LIABILITIES | ||||
Accrued compensation | ||||
Operating lease liabilities | ||||
Long-term debt | ||||
Tax Receivable Agreement liabilities | ||||
Deferred tax liabilities | ||||
Other non-current liabilities | ||||
Total non-current liabilities | $ | $ | ||
TOTAL LIABILITIES | $ | $ | ||
STOCKHOLDERS’ EQUITY | ||||
Class A common stock ($ shares issued and outstanding at December 31, 2025 and 2024, respectively) | ||||
Class B common stock ($ shares issued and outstanding at December 31, 2025 and 2024, respectively) | ||||
Class X common stock ($ | ||||
Preferred stock ($ December 31, 2025 and 2024) | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Accumulated other comprehensive income (loss) | ( | |||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. | $ | $ | ||
Non-controlling interests | ||||
Total stockholders’ equity | $ | $ | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
Net income | $ | $ | $ | |||
Adjustments to reconcile net income to cash flows provided by operating activities: | ||||||
Income from equity method investments | ( | ( | ( | |||
Amortization | ||||||
Depreciation | ||||||
Prepaid and deferred compensation expense | ||||||
Non-cash equity-based compensation | ||||||
Amortization of deferred debt issuance costs | ||||||
Amortization of interest rate cap premium | ||||||
Deferred income tax expense | ||||||
Deferred income tax expense from common control reorganizations | ||||||
Loss (gain) on Tax Receivable Agreement | ( | |||||
Changes in operating assets and liabilities, net of acquisitions: | ||||||
Commissions and fees receivable – net | ( | ( | ( | |||
Accrued interest liability | ||||||
Other current and non-current assets | ( | |||||
Other current and non-current liabilities | ( | |||||
Total cash flows provided by operating activities | $ | $ | $ | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity | ( | ( | ( | |||
Capital expenditures | ( | ( | ( | |||
Equity method investment in VSIC | ( | |||||
Asset acquisitions | ( | |||||
Repayments of prepaid incentives | ||||||
Total cash flows used in investing activities | $( | $( | $( | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
Proceeds from Senior Secured Notes | ||||||
Borrowings on Revolving Credit Facility | ||||||
Repayments on Revolving Credit Facility | ( | ( | ||||
Debt issuance costs paid | ( | ( | ||||
Proceeds from term debt | ||||||
Repayment of term debt | ( | ( | ( | |||
Receipt of contingently returnable consideration | ||||||
Payment of contingent consideration | ( | ( | ||||
Tax distributions to non-controlling LLC Unitholders | ( | ( | ( | |||
Receipt of taxes related to net share settlement of equity awards | ||||||
Taxes paid related to net share settlement of equity awards | ( | ( | ( | |||
Payment of Tax Receivable Agreement liabilities | ( | ( | ( | |||
Class A common stock dividends and Dividend Equivalents paid | ( | ( | ||||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders | ( | ( | ||||
Payments related to Ryan Re preferred units | ( | ( | ||||
Net change in fiduciary liabilities | ||||||
Total cash flows provided by (used in) financing activities | $ | $ | $( | |||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ( | |||||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | $( | $( | $( | |||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Beginning balance | ||||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Ending balance | $ | $ | $ | |||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||||
Cash and cash equivalents | $ | $ | $ | |||
Cash and cash equivalents held in a fiduciary capacity | ||||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | $ | $ | |||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2022 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | ||||||||||||||||
Forfeiture and retirement of common stock and clawback of vested equity awards | ( | — | — | — | ( | — | — | ( | ||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | |||||||||||||||
Forfeiture and retirement of common stock and clawback of vested equity awards | ( | — | — | — | ( | — | — | ( | ||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non- controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | ||||||||||||||||
Cash and common stock clawbacks related to vested equity awards | ( | — | — | — | ( | — | ||||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | ( | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non- controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investments’ other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at December 31, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Wholesale Brokerage | $ | $ | $ | |||
Binding Authority | ||||||
Underwriting Management | ||||||
Total Net commissions and fees | $ | $ | $ | |||
Velocity | USQ | 360 | JM Wilson | SSRU | Total | |||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | $ | ||||||
Commissions and fees receivable – net | ||||||||||||
Fiduciary cash and receivables | ||||||||||||
Goodwill | ||||||||||||
Customer relationships1 | ||||||||||||
Other intangible assets | ||||||||||||
Property and equipment – net | ||||||||||||
Lease right-of-use assets | ||||||||||||
Other current and non-current assets | ||||||||||||
Total assets acquired | $ | $ | $ | $ | $ | $ | ||||||
Accounts payable and accrued liabilities | ||||||||||||
Accrued compensation | ||||||||||||
Fiduciary liabilities | ||||||||||||
Operating lease liabilities | ||||||||||||
Deferred tax liabilities | ||||||||||||
Total liabilities assumed | $ | $ | $ | $ | $ | $ | ||||||
Net assets acquired | $ | $ | $ | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Total revenue | $ | $ | $ | |||
Net income | ||||||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Change in contingent consideration | $ | $( | $ | |||
Interest expense, net | ||||||
Total | $ | $( | $ | |||
Year Ended December 31, | ||||
2025 | 2024 | |||
Balance at beginning of period | $ | $ | ||
Write-offs | ( | ( | ||
Increase in provision | ||||
Balance at end of period | $ | $ | ||
As of December 31, | ||||
2025 | 2024 | |||
Prepaid expenses | $ | $ | ||
Insurance recoverable | ||||
Interest rate cap | ||||
Other current receivables | ||||
Total Other current assets | $ | $ | ||
Year Ended December 31, | ||||
2025 | 2024 | |||
Balance at beginning of period | $ | $ | ||
Acquisitions1 | ||||
Measurement period adjustments | ||||
Impact of exchange rate changes | ( | |||
Balance at end of period | $ | $ | ||
As of December 31, 2025 | As of December 31, 2024 | |||||||||||
Cost | Accumulated Amortization | Net Carrying Amount | Cost | Accumulated Amortization | Net Carrying Amount | |||||||
Customer relationships | $ | $( | $ | $ | $( | $ | ||||||
Internally developed software | ( | ( | ||||||||||
Other1 | ( | ( | ||||||||||
Total | $ | $( | $ | $ | $( | $ | ||||||
Customer Relationships | Internally Developed Software | Other | ||||
2026 | $ | $ | $ | |||
2027 | ||||||
2028 | ||||||
2029 | ||||||
2030 | ||||||
Thereafter | ||||||
Total | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Lease costs | ||||||
Operating lease costs | $ | $ | $ | |||
Short-term lease costs | ||||||
Operating lease costs | ||||||
Sublease income | ( | ( | ( | |||
Lease costs – net | $ | $ | $ | |||
Cash paid for amounts included in the measurement of lease liabilities | ||||||
Operating cash flows used for operating leases | $ | $ | $ | |||
Non-cash related activities | ||||||
Right-of-use assets obtained in exchange for new operating lease liabilities | ||||||
Amortization of right-of-use assets for operating leases | ||||||
Weighted-average discount rate (percent) | ||||||
Operating leases | ||||||
Weighted-average remaining lease term (years) | ||||||
Operating leases | ||||||
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total undiscounted future lease payments | $ | |
Less: Imputed interest | ( | |
Present value lease liabilities | $ |
As of December 31, | ||||
2025 | 2024 | |||
Term debt | ||||
Adjusted Term SOFR + SOFR + | $ | $ | ||
Senior secured notes | ||||
February 1, 2030 | ||||
August 1, 2032 | ||||
Revolving debt | ||||
SOFR + up to July 30, 2029 | ||||
Premium financing notes | ||||
Commercial notes, periodic interest and principal payments, expire May 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 21, 2026 | ||||
Commercial notes, periodic interest and principal payments, expired May 1, 2025 | ||||
Commercial notes, periodic interest and principal payments, expired June 1, 2025 | ||||
Commercial notes, periodic interest and principal payments, expired June 21, 2025 | ||||
Units subject to mandatory redemption | ||||
Total debt | $ | $ | ||
Less: Short-term debt and current portion of long-term debt | ( | ( | ||
Long-term debt | $ | $ | ||
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total repayments | $ | |
Less: Unamortized discounts and debt issuance costs | ( | |
Total | $ |
Year Ended December 31, 2025 | ||||||||
Restricted Stock | Weighted Average Grant Date Fair Value | Restricted Common Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Forfeited | ( | |||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, 2025 | ||||||||
IPO RSUs | Incentive RSUs | |||||||
Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Forfeited | ( | ( | ||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, 2025 | ||||||||
Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | |||||
Outstanding at beginning of period | $ | |||||||
Granted | ||||||||
Exercised | ( | ( | ||||||
Forfeited or expired | ( | ( | ||||||
Outstanding at end of period | $ | |||||||
Volatility | ||
Time to maturity (years) | ||
Risk-free rate | ||
Dividend yield | ||
Fair value per option | $ |
Aggregate intrinsic value ($ in thousands): | ||
Reload Options outstanding | $ | |
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | ||
Weighted-average remaining contractual term (in years): | ||
Reload Options outstanding | ||
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable |
Year Ended December 31, 2025 | ||||||||
IPO RLUs | Incentive RLUs | |||||||
Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Forfeited | ||||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, 2025 | ||||||||
Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | |||||
Unvested at beginning of period | $ | |||||||
Granted | ||||||||
Vested | ( | ( | ( | |||||
Forfeited | ||||||||
Unvested at end of period | $ | |||||||
Year Ended December 31, 2025 | ||||||||
PSUs | PLUs | |||||||
Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ||||||||
Forfeited | ( | |||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, | ||||
2025 | 2024 | |||
Volatility | ||||
Time to maturity (years) | ||||
Risk-free rate | ||||
RYAN stock price at valuation date | $ | $ | ||
Amount | Weighted Average Remaining Expense Period (Years) | |||
IPO RSUs | $ | |||
Incentive RSUs | ||||
Reload Options | ||||
Incentive Options | ||||
PSUs | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
Total unrecognized equity-based compensation expense | $ |
Recognized | |||||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
IPO awards | |||||
IPO RSUs and Staking Options | $ | $ | $ | ||
IPO RLUs and Staking Class C Incentive Units | |||||
Incremental Restricted Stock and Reload Options | |||||
Incremental Restricted Common Units and Reload Class C Incentive Units | |||||
Pre-IPO incentive awards | |||||
Restricted Stock | |||||
Restricted Common Units | |||||
Post-IPO incentive awards | |||||
Incentive RSUs | |||||
Incentive RLUs | |||||
Incentive Options | |||||
Class C Incentive Units | |||||
PSUs | |||||
PLUs | ( | ||||
Other expense | |||||
Director Stock Grants | |||||
Total equity-based compensation expense | $ | $ | $ | ||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Net income | $ | $ | $ | |||
Less: Net income attributable to non-controlling interests | ||||||
Net income attributable to Ryan Specialty Holdings, Inc. | $ | $ | $ | |||
Numerator: | ||||||
Net income attributable to Class A common shareholders | $ | $ | $ | |||
Add (less): Income attributed to substantively vested RSUs | ( | |||||
Net income attributable to Class A common shareholders – basic | $ | $ | $ | |||
Add: Income attributed to dilutive shares | ||||||
Net income attributable to Class A common shareholders – diluted | $ | $ | $ | |||
Denominator: | ||||||
Weighted-average shares of Class A common stock outstanding – basic | ||||||
Add: Dilutive shares | ||||||
Weighted-average shares of Class A common stock outstanding – diluted | ||||||
Earnings per share | ||||||
Earnings per share of Class A common stock – basic | $ | $ | $ | |||
Earnings per share of Class A common stock – diluted | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Conversion of non-controlling interest LLC Common Units1 | ||||||
Conversion of vested Class C Incentive Units1 | ||||||
Class C Incentive Units | ||||||
Year Ended December 31, | |||||||
Income Statement Caption | 2025 | 2024 | 2023 | ||||
Change in the fair value of the Deal- Contingent Forward | General and administrative | $ | $( | $( | |||
Total impact of derivatives not designated as hedging instruments | $ | $( | $( | ||||
Interest rate cap premium amortization | Interest expense, net | $( | $( | $( | |||
Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | ||||||
Total impact of derivatives designated as hedging instruments | $ | $ | $ | ||||
As of December 31, | |||||
Balance Sheet Caption | 2025 | 2024 | |||
Interest rate cap | Other current assets | $ | $ | ||
As of December 31, 2025 | As of December 31, 2024 | |||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||
Assets | ||||||||||||
Interest rate cap | $ | $ | $ | $ | $ | $ | ||||||
Contingently returnable consideration | ||||||||||||
Liabilities | ||||||||||||
Contingent consideration | ||||||||||||
Total assets and liabilities measured at fair value | $ | $ | $ | $ | $ | $ | ||||||
Year Ended December 31, | ||||
2025 | 2024 | |||
Assets | ||||
Balance at beginning of period | $ | $ | ||
Newly established assets due to acquisitions | ||||
Total gains included in earnings | ||||
Foreign currency translation adjustments included in OCI | ( | |||
Settlements | ( | |||
Balance at end of period | $ | $ | ||
Liabilities | ||||
Balance at beginning of period | $ | $ | ||
Newly established liabilities due to acquisitions1 | ||||
Total (gains) losses included in earnings | ( | |||
Foreign currency translation adjustments included in OCI | ||||
Settlements | ( | ( | ||
Acquisition measurement period adjustments | ( | |||
Balance at end of period | $ | $ | ||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
United States | $ | $ | $ | |||
Foreign | ( | |||||
Income before income taxes | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Current income tax expense (benefit) | ||||||
Federal | $( | $ | $ | |||
State | ||||||
Foreign | ||||||
Current income tax expense | $ | $ | $ | |||
Deferred income tax expense (benefit) | ||||||
Federal | ||||||
State | ( | |||||
Foreign | ( | ( | ( | |||
Deferred income tax expense | $ | $ | $ | |||
Total income tax expense (benefit) | ||||||
Federal | ||||||
State | ( | |||||
Foreign | ( | |||||
Total income tax expense | $ | $ | $ | |||
Year Ended December 31, | ||||||||||||
2025 | 2024 | 2023 | ||||||||||
Income taxes at U.S. federal statutory rate | $ | $ | $ | |||||||||
Nontaxable and nondeductible items | ||||||||||||
Income attributable to non-controlling interests and nontaxable income | ( | ( | ( | ( | ( | ( | ||||||
Nondeductible expenses | ||||||||||||
Effect of cross-border tax laws | ( | ( | ( | ( | ||||||||
Changes in valuation allowances | ||||||||||||
Equity-based compensation | ( | ( | ( | ( | ( | ( | ||||||
Common Control Reorganizations1 | ||||||||||||
Change in fair value of contingent consideration2 | ||||||||||||
Other federal | ( | ( | ( | ( | ||||||||
State and local income tax expense (benefit), net of federal benefit3 | ( | ( | ||||||||||
Foreign tax effects | ||||||||||||
United Kingdom | ||||||||||||
Nondeductible acquisition expenses | ||||||||||||
Nontaxable dividends and profit distributions | ( | ( | ||||||||||
Other | ( | ( | ||||||||||
Spain | ||||||||||||
Nondeductible profit distributions | ||||||||||||
Other | ( | ( | ||||||||||
Other foreign jurisdictions | ( | ( | ||||||||||
Income tax expense | $ | $ | $ | |||||||||
As of December 31, | ||||
2025 | 2024 | |||
Deferred tax assets | ||||
Net operating losses | $ | $ | ||
Investment in the LLC | ||||
Start-up costs | ||||
Equity-based compensation | ||||
Tax credits | ||||
Capitalized research and development | ||||
Other accrued items | ||||
Total deferred tax assets | $ | $ | ||
Valuation allowances | ( | ( | ||
Deferred tax assets, net of valuation allowances | $ | $ | ||
Deferred tax liabilities | ||||
Intangibles | ( | ( | ||
Fixed assets | ( | |||
Other accrued items | ||||
Deferred tax liabilities | $( | $( | ||
Net Deferred tax assets | $ | $ | ||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Federal | $ | $ | $ | |||
State and local | ||||||
Texas | ||||||
New York City | ||||||
Other state and local | ||||||
Foreign | ||||||
United Kingdom | ||||||
Netherlands | ||||||
Spain | ||||||
Sweden | ||||||
Other foreign | ||||||
Total cash paid for income taxes, net of refunds | $ | $ | $ | |||
Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |||||
Balance at December 31, 2023 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Remeasurement – change in state rate | ( | ( | ( | ( | ||||
Remeasurement – foreign tax credits | ( | ( | ||||||
Interest expense | ||||||||
Payments | ( | ( | ( | ( | ||||
Balance at December 31, 2024 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Interest expense | ||||||||
Payments | ( | ( | ( | ( | ||||
Balance at December 31, 2025 | $ | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Gain on interest rate cap | $( | $( | $( | |||
Gain on interest rate cap reclassified to earnings | ||||||
Foreign currency translation adjustments | ( | ( | ||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | ( | ||||
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss)1 | Total | |||||
Balance at December 31, 2022 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at December 31, 2023 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $( | $ | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at December 31, 2024 | $ | $( | $( | $( | ||||
Other comprehensive income before reclassifications | ||||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at December 31, 2025 | $ | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Net commissions and fees | $ | $ | $ | |||
Fiduciary investment income | ||||||
Total revenue | $ | $ | $ | |||
Compensation-related expense1 | ||||||
General and administrative expense2 | ||||||
Other segment items3 | ||||||
Depreciation and amortization | ||||||
Change in contingent consideration | ( | |||||
Interest income | ( | ( | ( | |||
Interest expense | ||||||
Income from equity method investments | ( | ( | ( | |||
Other non-operating loss (income) | ( | |||||
Income tax expense | ||||||
Net income | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
United States | $ | $ | $ | |||
Foreign | ||||||
Total revenue | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Cash paid for: | ||||||
Interest, net1 | $ | $ | $ | |||
Non-cash investing and financing activities: | ||||||
Non-controlling interest holders’ tax distributions declared but unpaid | $ | $ | $ | |||
Tax Receivable Agreement liabilities | ||||||
Dividend Equivalents and Declared Distributions liabilities | ||||||
Contingently returnable consideration | ||||||
Contingent consideration liabilities | ||||||
Year Ended December 31, | ||||||
2024 | 2023 | Total | ||||
Operations and technology optimization | $ | $ | $ | |||
Compensation and benefits | ||||||
Asset impairment and other termination costs | ||||||
Total | $ | $ | $ | |||
Operations and Technology Optimization | Compensation and Benefits | Asset Impairment and Other Termination Costs | Total | |||||
Balance at December 31, 2023 | $ | $ | $ | $ | ||||
Accrued costs | ||||||||
Payments | ( | ( | ( | |||||
Non-cash adjustments | ( | ( | ||||||
Balance at December 31, 2024 | $ | $ | $ | $ |
Exhibit Number | Description | ||
3.1 | Amended and Restated Certificate of Incorporation of Ryan Specialty Holdings, Inc., dated May 30, 2025 (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on June 4, 2025). | ||
3.2 | Amended and Restated Bylaws of Ryan Specialty Holdings, Inc., dated May 30, 2025 (incorporated by reference to Exhibit 3.2 to the Registrant’s Form 8-K filed on June 4, 2025). | ||
4.1 | Registration Rights Agreement, dated July 26, 2021, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on July 27, 2021). | ||
4.2 | Indenture, dated as of February 3, 2022, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on February 7, 2022). | ||
4.3 | Form of 4.375% Senior Secured Notes due 2030 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Form 8-K filed on February 7, 2022). | ||
4.4 | Indenture, dated as of September 19, 2024, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on September 19, 2024). | ||
4.5 | Form of 5.875% Senior Secured Notes due 2032 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Form 8-K filed on September 19, 2024). | ||
4.6 | First Supplemental Indenture to that certain Indenture, dated as of September 19, 2024, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.2 to the Registrant’s Form 8-K filed on December 9, 2024). | ||
4.7 | Description of Capital Stock, filed herewith. | ||
10.1 | Amended and Restated Tax Receivable Agreement, dated as of August 9, 2022, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on August 12, 2022). |
10.2 | Eighth Amended and Restated Limited Liability Company Agreement of Ryan Specialty, LLC, dated as of July 5, 2023, by and among Ryan Specialty, LLC and the other signatories party thereto, (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on November 03, 2023). | ||
10.3 | + | Form of Director and Officer Indemnification Agreement, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on June 21, 2021). | |
10.4 | + | Indemnification Agreement, by and among Ryan Specialty Holdings, Inc. and Patrick G. Ryan, dated as of July 26, 2021 (incorporated by reference to Exhibit 10.4 to the Registrant’s Form 8-K filed on July 27, 2021). | |
10.5 | Director Nomination Agreement, dated as of July 26, 2021, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.5 to the Registrant’s Form 8- K filed on July 27, 2021). | ||
10.6 | + | Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Quarterly Report on Form 10-Q filed on August 12, 2022). | |
10.7 | + | First Amendment to the Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan, (incorporated by reference to Exhibit 10.8 to the Registrant’s Form 10-K filed on March 1, 2023). | |
10.8 | + | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (Staking Unit) (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.9 | + | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (Reload Unit) (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.1 | + | Ryan Specialty Holdings, Inc. Form of Common Unit Grant Agreement (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.11 | + | Ryan Specialty Holdings, Inc. Form of Restricted Stock Unit Agreement (Non-Employee Directors), (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on March 16, 2022). | |
10.12 | + | Ryan Specialty Holdings, Inc. Form of Restricted LLC Unit Agreement (2022), (incorporated by reference to Exhibit 10.11 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.13 | + | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (PSI Units), (incorporated by reference to Exhibit 10.12 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.14 | + | Ryan Specialty Holdings, Inc. Form of Performance-Based Restricted Stock Unit Agreement (DELTA PSUS), (incorporated by reference to Exhibit 10.14 to the Registrant’s Form 10-Q filed on May 30, 2024). | |
10.15 | + | Ryan Specialty Holdings, Inc. Form of Performance-Based Restricted LLC Unit Agreement (DELTA PLUS), (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-Q filed on May 30, 2024). | |
10.16 | Seventh Amendment to the Credit Agreement, dated September 13, 2024, including Exhibit A, a conformed copy of the Credit Agreement, dated as of September 1, 2020, among Ryan Specialty, LLC and JPMorgan Chase Bank, N.A., as administrative agent and the other lenders party thereto, as amended March 30, 2021, July 26, 2021, August 13, 2021, April 29, 2022, January 19, 2024, July 30, 2024 and September 13, 2024, (incorporated by reference to Exhibit 10.16 to the Registrant’s Form 10-Q filed on October 31, 2024). | ||
10.17 | Third Amended and Restated Limited Liability Company Operating Agreement of New Ryan Specialty, LLC dated as of July 5, 2023, by and among New Ryan Specialty, LLC and the other signatories party thereto, (incorporated by reference to Exhibit 10.20 to the Registrant’s Quarterly Report on Form 10-Q filed on November 03, 2023). | ||
10.18 | First Amendment to the Third Amended and Restated Limited Liability Company Operating Agreement of New Ryan Specialty, LLC, dated as of April 30, 2024, by and among New Ryan Specialty, LLC, and the other signatories party thereto, (incorporated by reference to Exhibit 10.18 to the Registrant’s Quarterly Report on Form 10-Q filed on August 02, 2024). | ||
10.19 | + | Ryan Specialty Group Services, LLC Executive Severance Plan, (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on February 28, 2024). | |
19.1 | Ryan Specialty Holdings, Inc. Insider Trading Policy dated May 1, 2023 (incorporated by reference to Exhibit 19.1 to the Registrant’s Form 10-K filed on February 21, 2025). | ||
21.1 | Subsidiaries of the Registrant, filed herewith. | ||
23.1 | Consent of Deloitte & Touche LLP, filed herewith. | ||
31.1 | Certification of the Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | ||
31.2 | Certification of the Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | ||
32.1 | * | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, furnished herewith. | |
32.2 | * | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, furnished herewith. | |
97.1 | Clawback Policy Pursuant to Rule 10D-1 under the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 97.1 to the Registrant’s Form 10-K filed on February 28, 2024). | ||
101.INS | Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | ||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Date February 12, 2026 | |||
Ryan Specialty Holding, Inc | |||
By: | /s/ Timothy W. Turner | ||
Timothy W. Turner, Chief Executive Officer | |||
Signature | Title | Date |
/s/ Patrick G. Ryan | Executive Chairman and Chairman of the Board of Director | February 12, 2026 |
Patrick G. Ryan | ||
/s/ Timothy W. Turner | Chief Executive Officer and Director (Principal Executive Officer) | February 12, 2026 |
Timothy W. Turner | ||
/s/ Janice M. Hamilton | Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | February 12, 2026 |
Janice M. Hamilton | ||
/s/ Henry S. Bienen | Director | February 12, 2026 |
Henry S. Bienen | ||
/s/ David P. Bolger | Director | February 12, 2026 |
David P. Bolger | ||
/s/ Michael G Bungert | Director | February 12, 2026 |
Michael G. Bungert | ||
/s/ Michelle L. Collins | Director | February 12, 2026 |
Michelle L. Collins | ||
/s/ Francesca Cornelli | Director | February 12, 2026 |
Francesca Cornelli | ||
/s/ Nicholas D. Cortezi | Director | February 12, 2026 |
Nicholas D. Cortezi | ||
/s/ Anthony J. Kuczinski | Director | February 12, 2026 |
Anthony J. Kuczinski | ||
/s/ Michael D. O’Halleran | Director | February 12, 2026 |
Michael D. O’Halleran | ||
/s/ John W. Rogers, Jr | Director | February 12, 2026 |
John W. Rogers, Jr | ||
/s/ Patrick G. Ryan, Jr. | Director | February 12, 2026 |
Patrick G. Ryan, Jr. |